{"id":"https://openalex.org/W2177067006","doi":null,"title":"AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia.","display_name":"AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia.","publication_year":2010,"publication_date":"2010-02-01","ids":{"openalex":"https://openalex.org/W2177067006","mag":"2177067006","pmid":"https://pubmed.ncbi.nlm.nih.gov/20140822"},"language":"en","primary_location":{"id":"pmid:20140822","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20140822","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in molecular therapeutics","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041988234","display_name":"Fabien Mong\u00e9lard","orcid":"https://orcid.org/0000-0002-5929-6120","observed_orcids":["https://orcid.org/0000-0002-5929-6120"]},"institutions":[{"id":"https://openalex.org/I113428412","display_name":"\u00c9cole Normale Sup\u00e9rieure de Lyon","ror":"https://ror.org/04zmssz18","country_code":"FR","type":"education","lineage":["https://openalex.org/I113428412","https://openalex.org/I203339264"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabien Mongelard","raw_affiliation_strings":["Universit\u00e9 de Lyon, Ecole Normale Sup\u00e9rieure de Lyon, CNRS-USR and IFR Biosciences, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Lyon, Ecole Normale Sup\u00e9rieure de Lyon, CNRS-USR and IFR Biosciences, France","institution_ids":["https://openalex.org/I113428412","https://openalex.org/I1294671590"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014995390","display_name":"Philippe Bouvet","orcid":"https://orcid.org/0000-0003-4524-2233","observed_orcids":["https://orcid.org/0000-0003-4524-2233"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe Bouvet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.1217,"has_fulltext":false,"cited_by_count":163,"citation_normalized_percentile":{"value":0.93161007,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"12","issue":"1","first_page":"107","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.0430000014603138,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10207","display_name":"Advanced biosensing and bioanalysis techniques","score":0.022700000554323196,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nucleolin","display_name":"nucleolin","score":0.8920000195503235},{"id":"https://openalex.org/keywords/aptamers","display_name":"aptamers","score":0.671999990940094},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9449999928474426},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.7609999775886536},{"id":"https://openalex.org/keywords/cytarabine-combination-therapy","display_name":"cytarabine combination therapy","score":0.875},{"id":"https://openalex.org/keywords/tumor-cell-internalization","display_name":"tumor cell internalization","score":0.7770000100135803},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.8389999866485596},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.49300000071525574}],"concepts":[{"id":"https://openalex.org/C2776525860","wikidata":"https://www.wikidata.org/wiki/Q18029887","display_name":"Nucleolin","level":4,"score":0.973054051399231},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6149083375930786},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.5141687393188477},{"id":"https://openalex.org/C128972844","wikidata":"https://www.wikidata.org/wiki/Q418722","display_name":"Aptamer","level":2,"score":0.46216392517089844},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4562801122665405},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4352724552154541},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43115469813346863},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3611730933189392},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3328193128108978},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19476443529129028},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.18336233496665955},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C183873130","wikidata":"https://www.wikidata.org/wiki/Q30869","display_name":"Nucleolus","level":3,"score":0.0},{"id":"https://openalex.org/C2780723820","wikidata":"https://www.wikidata.org/wiki/Q1934178","display_name":"Nucleus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000097796","descriptor_name":"Nucleolin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009838","descriptor_name":"Oligodeoxyribonucleotides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009838","descriptor_name":"Oligodeoxyribonucleotides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010750","descriptor_name":"Phosphoproteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D010750","descriptor_name":"Phosphoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016601","descriptor_name":"RNA-Binding Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016601","descriptor_name":"RNA-Binding Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D052157","descriptor_name":"Aptamers, Nucleotide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D052157","descriptor_name":"Aptamers, Nucleotide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D052157","descriptor_name":"Aptamers, Nucleotide","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:20140822","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20140822","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in molecular therapeutics","raw_type":"Journal Article"},{"id":"mag:2177067006","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20140822","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2555823404","https://openalex.org/W4386942017","https://openalex.org/W1709396952","https://openalex.org/W2986752244","https://openalex.org/W7204109360","https://openalex.org/W7098696657","https://openalex.org/W2118908256","https://openalex.org/W2556094713","https://openalex.org/W2223300916","https://openalex.org/W2319951868"],"abstract_inverted_index":{"In":[0,149],"development":[1],"by":[2],"Antisoma":[3],"plc,":[4],"AS-1411":[5,33,52,114,166,196,215],"is":[6,60,68,75,102,239],"the":[7,20,64,78,82,96,132,206,232],"first":[8],"oligodeoxynucleotide":[9],"aptamer":[10],"to":[11,37,54,56,208,211,217,241],"reach":[12],"phase":[13,151,192],"I":[14,152],"and":[15,59,90,135,169,177],"II":[16,193],"clinical":[17,153],"trials":[18],"for":[19,222],"potential":[21],"treatment":[22,111,224],"of":[23,81,95,99,125,146,195,231,234,236],"cancers,":[24],"including":[25],"acute":[26],"myelogenous":[27],"leukemia":[28],"(AML).":[29],"As":[30],"an":[31,69],"aptamer,":[32],"does":[34],"not":[35],"appear":[36],"engage":[38],"in":[39,88,131,137,140,155,172,184,197,201,225,243],"hybridization-requiring":[40],"pathways":[41],"such":[42],"as":[43],"antisense":[44],"effect,":[45],"siRNA":[46],"or":[47],"triple":[48],"helix":[49],"formation.":[50],"Instead,":[51],"appears":[53,216],"bind":[55],"nucleolin":[57,84],"specifically,":[58],"subsequently":[61],"internalized":[62],"into":[63],"tumor":[65,126,144],"cell.":[66],"Nucleolin":[67],"abundant":[70],"protein,":[71],"with":[72,77,112,143,157,161,187,199,203],"expression":[73],"that":[74,104],"correlated":[76],"proliferative":[79],"status":[80],"cell:":[83],"levels":[85],"are":[86,108],"higher":[87],"tumors":[89],"actively":[91],"dividing":[92],"cells.":[93],"Because":[94],"multifunctional":[97],"nature":[98],"nucleolin,":[100],"it":[101],"probable":[103],"many":[105],"secondary":[106],"targets":[107],"affected":[109],"following":[110],"AS-1411.":[113],"has":[115],"demonstrated":[116,205],"preclinical":[117],"growth":[118],"inhibition":[119],"activity":[120],"against":[121],"a":[122,150,219],"wide":[123],"variety":[124],"cell":[127,189],"lines":[128],"at":[129,163],"concentrations":[130],"micromolar":[133],"range,":[134],"resulted":[136],"good":[138],"efficacy":[139],"mice":[141],"xenografted":[142],"cells":[145],"human":[147],"origin.":[148],"trial":[154,194],"patients":[156,186,202],"advanced,":[158],"refractory":[159],"cancers":[160],"metastases":[162],"multiple":[164],"sites,":[165],"was":[167],"safe":[168],"well":[170],"tolerated;":[171],"addition,":[173],"one":[174,178],"complete":[175],"response":[176,181],"ongoing":[179],"partial":[180],"were":[182],"reported":[183],"two":[185],"renal":[188],"carcinoma.":[190],"A":[191,228],"combination":[198,207],"cytarabine":[200,212],"AML":[204],"be":[209,218],"superior":[210],"alone.":[213],"Thus,":[214],"promising":[220],"candidate":[221],"cancer":[223],"these":[226],"pathologies.":[227],"greater":[229],"understanding":[230],"mechanism":[233],"action":[235],"this":[237],"agent":[238],"essential":[240],"aid":[242],"future":[244],"research.":[245]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}